KPV
Also known as: KPV Tripeptide, Alpha-MSH Fragment 11-13, Lysine-Proline-Valine
KPV is a tripeptide (Lys-Pro-Val) derived from the C-terminal sequence of alpha-melanocyte-stimulating hormone (alpha-MSH), an endogenous neuropeptide with broad anti-inflammatory activity. Despite being a very small fragment, KPV retains the anti-inflammatory signaling capacity of the parent molecule. It inhibits NF-kB activation and reduces the production of pro-inflammatory cytokines including TNF-alpha, IL-6, and IL-1beta. Research has demonstrated its efficacy in models of inflammatory bowel disease, where it reduces colonic inflammation when administered orally. KPV also exhibits antimicrobial properties against certain bacteria, making it a dual-function peptide for gut and immune health.
Growing body of research
Well-tolerated with minimal side effects
How It Works
KPV is a tripeptide from alpha-MSH that inhibits NF-kB activation and suppresses pro-inflammatory cytokines with antimicrobial properties.
Key Benefits
- Potent anti-inflammatory effects via NF-kB inhibition
- Reduces pro-inflammatory cytokine production
- Supports gut mucosal healing
- Exhibits antimicrobial activity
- May improve symptoms of inflammatory bowel conditions
- Well-tolerated with minimal systemic effects
Who May Benefit
- Individuals with inflammatory bowel conditions
- People with inflammatory skin conditions
- Those seeking gut inflammation reduction
- Those wanting anti-inflammatory support without immunosuppression
Dosage & Administration
Expected Timeline
Anti-inflammatory effects in 1-2 weeks. Gut improvements at 2-4 weeks. Skin at 4-6 weeks.
Safety Information
Possible Side Effects
Contraindications
Dr. Taylor's 2 Cents
“KPV is a powerhouse anti-inflammatory that I use extensively for gut health. It's a tiny tripeptide derived from alpha-MSH, but it packs a serious punch against NF-kB-driven inflammation. The IBD research is particularly promising. I use it orally for gut-specific inflammation and subcutaneously for systemic inflammatory conditions. It's one of the best-tolerated peptides I prescribe.”
Discuss with Dr. Taylor →Frequently Asked Questions
What is KPV?
What conditions is it used for?
How is it administered?
Is KPV safe?
How does it compare to other anti-inflammatories?
Published Research
PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation
Dalmasso G, Charrier-Hisamuddin L, Nguyen HT, Yan Y, Sitaraman S, Merlin D · Gastroenterology (2008)
Key Finding: Oral KPV reduced incidence of colitis in mice by inhibiting NF-kB and MAPK inflammatory signaling, establishing KPV as a potential therapeutic for inflammatory bowel disease.
Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease
Kannengiesser K, Maaser C, Heidemann J, et al. · Inflammatory Bowel Diseases (2008)
Key Finding: KPV led to earlier recovery and significantly stronger weight regain in colitis models, and rescued all treated animals from death during severe colitis.
Protocols Featuring KPV
Related Peptides
Related Reading
Want personalized guidance?
Consult with Dr. Patrick Taylor for a comprehensive evaluation and personalized protocol.
Book a ConsultationMedical Disclaimer: This information is for educational purposes only and is not medical advice. Consult a healthcare provider before starting any peptide protocol.